An evaluation of the relationship between specialist training in cardiology and implementation of evidence-based care of patients following acute myocardial infarction

International Journal of Cardiology

Volumn 96, Issue 3, 2004, Pages 335-340

  Dorsch, M F ^a   Lawrance, R A ^a   Sapsford, R J ^a   Durham, N ^a   Das, R ^a   Jackson, B M ^a   Morrell, C ^a   Ball, S G ^a   Robinson, M B ^a   Hall, A S ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Acute myocardial infarction; Evidence based strategies; Speciality of physician

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; EVALUATION; EVIDENCE BASED MEDICINE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT CARE; PHYSICIAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOLOGY; EVIDENCE-BASED MEDICINE; FEMALE; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES;

EID: 4143060412     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.05.038     Document Type: Article

References (28)

1. No authors listed Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 2(8607):1988 (Aug. 13);349-360
2. The Acute Infarction Ramipril Efficacy (AIRE) study Investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-828
3. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N. Engl. J. Med. 327(10):1992;669-677
4. No authors listed Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 344(8934):1994;1383-1389
5. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators. N. Engl. J. Med. 335(14):1996 (Oct. 3);1001-1009
6. Torp-Pedersen C., Kober L. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation. Lancet. 354(9172):1999 (Jul. 3);9-12
7. Collinson J., Flather M.D., Fox K.A., Findlay I., Rodrigues E., Dooley P., et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur. Heart J. 21(17):2000 (Sep.);1450-1457
8. Friedmann P.D., Brett A.S., Mayo-Smith M.F. Differences in generalists' and cardiologists' perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease. Ann. Intern. Med. 124(4):1996 (Feb. 15);414-421
9. Ayanian J.Z., Hauptman P.J., Guadagnoli E., Antman E.M., Pashos C.L., McNeil B.J. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N. Engl. J. Med. 332(7):1995 (Feb. 16);473-474
10. Hlatky M.A., Cotugno H.E., Mark D.B., O'Connor C., Califf R.M., Pryor D.B. Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987. Am. J. Cardiol. 61:1988;515-518
11. Hlatky M.A., Cotugno H.E., O'Connor C., Mark D.B., Pryor D.B., Califf R.M. Adoption of thrombolytic therapy in the management of acute myocardial infarction. Am. J. Cardiol. 61:1988;510-514
12. Go A.S., Rao R.K., Dauterman K.W., Massie B.M. A systematic review of the effects of physician specialty on the treatment of coronary disease and heart failure in the United States. Am. J. Med. 108(3):2000 (Feb. 15);259-260
13. Jollis J.G., DeLong E.R., Peterson E.D., Muhlbaier L.H., Fortin D.F., Califf R.M., et al. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N. Engl. J. Med. 335(25):1996 (Dec. 19);1880-1887
14. Chen J., Radford M.J., Wang Y., Krumholz H.M. Care and outcomes of elderly patients with acute myocardial infarction by physician specialty: the effects of comorbidity and functional limitations. Am. J. Med. 108(6):2000 (Apr. 15);460-469
15. Davie A.P., McMurray J.J. ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians? Postgrad. Med. J. (889):1999 (Nov.);703
16. Lim L.L., Heller R.F., O'Connell R.L., D'Este K. Stated and actual management of acute myocardial infarction among different specialties. Med. J. Aust. 172(5):2000 (Mar. 6);197-198
17. Dorsch M.F., Lawrance R.A., Sapsford R.J., et al. A simple benchmark for evaluating quality of care of patients following acute myocardial infarction. Heart. 86(2):2001;150-154
18. Lawrance R.A., Dorsch M.F., Sapsford R.J., et al. Cumulative case-mix adjusted mortality rates of Acute Myocardial Infarction patients: early spotting of variations in clinical practice. Observational Study. BMJ. 323:2001;324-327
19. Gunnar R.M., Passamani E.R., Bourdillon P.D., et al. Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. J. Am. Coll. Cardiol. 16(2):1990;249-292
20. Gottwik M., Zahn R., Schiele R., et al. Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology. Eur. Heart J. 22:2001;1794-1801
21. Whyte J.J., Filly A.L., Jollis J.G. Treatment of hyperlipidemia by specialists versus generalists as secondary prevention of coronary artery disease. Am. J. Cardiol. 80(10):1997 (Nov. 15);1345-1347
22. Stumerar S., Avorn J. Principals of educational outreach (academic detailing) to improve clinical decision making. JAMA. 263:1990;549-556
23. Norris R.M., Roy S., Dixon G.F. Clinical trials and clinical practice. Lancet. 342(8883):1993 (Nov. 27);1366
24. Ketley D., Woods K.L. Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet. 342(8876):1993 (Oct. 9);891-894
25. Clinical trials and clinical practice - editorial. Lancet. 342(8876):1993 (Oct. 9);877-878
26. Ward M.M., Leigh J.P., Fries J.F. Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care. Arch. Intern. Med. 153(19):1993 (Oct. 11);2229-2237
27. Zeiger R.S., Heller S., Mellon M.H., Wald J., Falkoff R., Schatz M. Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits. J. Allergy Clin. Immunol. 87(6):1991 (Jun.);1160-1168
28. Donohoe M.T. Comparing generalist and specialty care: discrepancies, deficiencies, and excesses. Arch. Intern. Med. 8(15):1998 (Aug. 10-15);1596-1608